Using immunohistochemical staining and digital image analysis, SLC22A3 expression was examined in 42 HNSCC patients who were postoperatively treated with or without adjuvant chemotherapy. The gene discussed is SLC22A3; the disease is head and neck squamous cell carcinoma.